XIX International AIDS Conference

MOSA10 Research for New HIV/AIDS Prevention Technologies: Community Perspectives
  Non-Commercial Satellite
Venue: Mini Room 8
Time: 23.07.2012, 07:00 - 08:30
Chair: Kevin Moody, Netherlands
Organiser: African AIDS Vaccine Partnership (AAVP), AVAC:Global Advocacy for HIV Prevention, Global Network of People Living with HIV (GNP+), International AIDS Vaccine Initiative (IAVI), and International Partnership for Microbicides (IPM)
Developing effective prevention tools requires community involvement in every stage of testing and targeting. The session will discuss how community engagement can inform microbicide, PrEP and vaccine research, help ensure future access for diverse populations, and help shape comprehensive combination prevention programs.

. Review prevention needs for different populations, and how new prevention technologies (NPTs) in the pipeline could combine with existing tools.
. Focus on how efficacy of biomedical interventions is determined by cultural, behavioral and biological factors and power inequality.
. Update recent scientific advances in development of NPTs- including proof of concept and efficacy of microbicides, vaccines, PrEP
. Preparing for roll-out and access:
- Challenges of integrating NPTs into existing prevention interventions and potential mitigation strategies
- Engaging communities to ensure new tools are acceptable and accessible to all


State of the Field, New Prevention Technologies

L. Bekker, South Africa

Community perspectives panel

A. Yuvaraj, India
G. Adeyemo, Nigeria
P. Semugoma, Uganda

Powerpoints presentations
State of the Field, New Prevention Technologies - Linda-Gail Bekker

Rapporteur report

CPC report by Garry Brough

Kevin Moody of GNP+ introduced the session by stressing the need to involve the community in the process, implementation and monitoring of prevention trials, to ensure that human rights are respected. Linda-Gail Bekker provided a comprehensive overview of the biological issues of HIV transmission and treatment. She addressed the historical failure of ABC and the difficulty in maintaining sustained condom use. While circumcision shows significant benefits and ARVs are able to both reduce infectiousness (Treatment as Prevention) and prevent transmission (Pre-Exposure Prophylaxis), cost, supply and adherence issues remain. Both biological and behavioral interventions are needed to ensure optimum outcomes and innovative multidisciplinary trials which bring together a range of workable options should be explored.

The panel then framed the discussion for their own communities:

Anandi Yuvari provided the perspective of women in India, emphasizing the need for a range of prevention methods which take into account not only diverse personal needs and preferences, but the issues of gender inequality and lack of education, resulting in a need for both ARV and non-ARV-based solutions.

Gabriel Adeyemo spoke of young people in Nigeria who report variable use of condoms, limited by religious and traditional cultural beliefs and for whom pregnancy or the pleasure of sex are of greater immediate concern than HIV. He stressed the need for education, behavioral interventions and a range of biomedical prevention tools over medication alone, which may not be adhered to.

Finally, Paul Semugoma highlighted the difficulties of involving MSM in community research in Uganda when the country refuses to recognize that they even exist. Furthermore, with a lack of political will to highlight and promote research successes, community activism is needed to drive forward new prevention technologies such as PrEP. His plea to researchers was ‘don’t study a community, study with a community’ - engaging and interesting participants in the process and its results in turn leads to greater dissemination of the findings within the very communities it aims to benefit.


    The organizers reserve the right to amend the programme.

Contact Us | Site map © 2012 International AIDS Society